ArticleBMC infectious diseases2026
Coagulation risk in sepsis patients with elevated lactate-to-albumin ratio: a retrospective cohort study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Admission Biomarkers as Predictors of Mortality in Comatose Patients in the Intensive Care Unit: A Retrospective Pilot Study.Diagnostics (Basel, Switzerland) · 2026Article
- Relationship Between the Lactate-to-Albumin Ratio and Acute Kidney Injury in Patients with Pulmonary Embolism: A Retrospective Cohort Study.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSepsis-induced coagulopathy (SIC) is commonly observed in patients with sepsis and is correlated with an elevated risk of mortality. The objective of this study is to analyse the association between the lactate-to-albumin ratio (LAR) and the occurrence of SIC, as well as all-cause mortality.
methodsFrom the MIMIC-IV3.1 database, patients with sepsis who fulfilled the inclusion criteria were selected. The relationship between LAR and SIC was assessed by constructing a multivariate logistic regression model and performing Restricted cubic spline (RCS) analysis. To evaluate the predictive ability of different biomarkers for SIC, we performed ROC curve analysis. Subgroup analysis verifies the robustness of the results. Additionally, Cox regression analysis was conducted to investigate the association between LAR and mortality.
resultsA total of 8,661 patients with sepsis were included in the final analysis, of whom 5,784 developed SIC. In the comprehensive logistic regression model, each additional unit of LAR increased the odds of SIC rather by 1.85 (OR, 2.85, 95% CI, 2.48-3.28; p < 0.001). The odds of SIC rather in the highest LAR group was significantly increased (T3 vs T1: OR, 3.57; 95% CI, 3.06-4.17; p < 0.001). The relationship between LAR levels and SIC incidence was found to be nonlinear and positive, as revealed by RCS analysis. ROC analysis indicated superior predictive performance of LAR (AUC = 0.71) compared to albumin (AUC = 0.61) or lactate (AUC = 0.69). Subgroup analysis indicates a stable relationship between LAR and SIC. Moreover, an increase in LAR was correlated with a heightened risk of mortality at both 28 days and 360 days (28-d HR, 1.15; 95% CI, 1.11-1.19; 360-d HR, 1.14; 95% CI, 1.11-1.18; all p < 0.001).
conclusionsObservational findings indicate that elevated early LAR levels may be associated with increased rates of SIC and all-cause mortality in patients with sepsis. However, further prospective studies are needed to validate these associations and assess their clinical utility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.